PDL BioPharma Inc (PDLI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:PDL BioPharma Inc (PDLI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011026
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc (PDLI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PDL BioPharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PDL BioPharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PDL BioPharma Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 10
Venture Financing 12
Direct Flow Medical Raises US$50 Million In Venture Financing 12
Kaleo To Raise US$150 Million In Venture Financing 13
Equity Offering 14
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 14
Debt Offering 16
PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 16
PDL BioPharma Inc – Key Competitors 17
PDL BioPharma Inc – Key Employees 18
PDL BioPharma Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Legal and Regulatory 20
Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PDL BioPharma Inc, Medical Equipment, Key Facts, 2016 2
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PDL BioPharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PDL BioPharma Inc, Deals By Market, 2011 to YTD 2017 8
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 10
Direct Flow Medical Raises US$50 Million In Venture Financing 12
Kaleo To Raise US$150 Million In Venture Financing 13
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 14
PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 16
PDL BioPharma Inc, Key Competitors 17
PDL BioPharma Inc, Key Employees 18
PDL BioPharma Inc, Subsidiaries 19

★海外企業調査レポート[PDL BioPharma Inc (PDLI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edcon Holdings (Proprietary) Limited:戦略・SWOT・企業財務分析
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Royal Dutch Shell Plc (RDSA):企業の財務・戦略的SWOT分析
    Royal Dutch Shell Plc (RDSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務情報
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Patel Engineering Ltd
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Golden Star Resources Ltd:企業の戦略・SWOT・財務情報
    Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • Aurigene Discovery Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurigene Discovery Technologies Ltd (Aurigene), a subsidiary of Dr. Reddy's Laboratories Ltd, is a biotechnology company that develops small molecule and peptide therapeutics. The company develops small molecule and peptide drug candidates for oncology and inflammatory diseases. It owns inte …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Glenmede Corporation:企業の戦略・SWOT・財務情報
    Glenmede Corporation - Strategy, SWOT and Corporate Finance Report Summary Glenmede Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ramky Infrastructure Limited:企業の戦略・SWOT・財務情報
    Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Arab Petroleum Investments Corp:企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • MedMira Inc (MIR):企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Advanced Energy Industries Inc (AEIS):電力:M&Aディール及び事業提携情報
    Summary Advanced Energy Industries, Inc. (Advanced Energy) is a provider of power conversion, measurement and control solutions. The company designs, manufactures, sells, and supports power conversion products and solutions. These products are used in various applications ranging from manufacturing …
  • Advanced Info Service Public Co Ltd (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service Public Co Ltd (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Folksam:企業のM&A・事業提携・投資動向
    Folksam - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Folksam Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Black Hills Corporation (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Trimble Inc (TRMB):企業の財務・戦略的SWOT分析
    Trimble Inc (TRMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • North Eastern Electric Power Corporation Ltd:企業の戦略的SWOT分析
    North Eastern Electric Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Hunting PLC (HTG):企業の財務・戦略的SWOT分析
    Hunting PLC (HTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆